8-2-337, ROAD NO.3 BANJARA HILLS, HYDERABAD, K7
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation Regarding Board Meeting and Trading Window Closure
Schedules Analyst / Institutional Investor Meetings
Exclusive Agreement for Qdenga® Distribution in India
USFDA Completes Records Assessment at Mexico Facility
Allotment of Equity Shares on Exercise of Stock Options under ESOPs
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings
Submits Form 6-K
Annual and Transition Report of Foreign Private Issuers
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
No filings found
Initial Statement of Beneficial Ownership
Registration Statement for Depositary Shares
Confidential Treatment Order
Submission Upload
Correspondence